Drug Shortage Report for JAMP-ZOLEDRONIC ACID
| Report ID | 137039 |
| Drug Identification Number | 02482525 |
| Brand name | JAMP-ZOLEDRONIC ACID |
| Common or Proper name | Zoledronic Acid |
| Company Name | JAMP PHARMA CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | ZOLEDRONIC ACID |
| Strength(s) | 4MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 1x5mL |
| ATC code | M05BA |
| ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-10-01 |
| Estimated end date | 2021-10-15 |
| Actual end date | 2021-11-01 |
| Shortage status | Resolved |
| Updated date | 2021-11-24 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2021-11-24 | French | Compare |
| v7 | 2021-11-24 | English | Compare |
| v6 | 2021-09-16 | French | Compare |
| v5 | 2021-09-16 | English | Compare |
| v4 | 2021-07-30 | French | Compare |
| v3 | 2021-07-30 | English | Compare |
| v2 | 2021-04-07 | French | Compare |
| v1 | 2021-04-07 | English | Compare |
Showing 1 to 8 of 8